Replimune Group’s Sushil Patel proposes $288K stock sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Replimune Group, Inc. (REPL) Chief Strategy Officer Sushil Patel reported a proposed sale of 15,331 common shares, with an approximate sale date of November 20, 2026, and an aggregate market value of $288,223. The notice gives August 21, 2026 as the adoption date for a Rule 10b5-1 plan. Patel acquired the shares through an RSU vest on May 15, 2023.
Key Figures
Key Terms
Rule 10b5-1 regulatory
RSU financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.